Figure 1. IBD patients with BSI during the study period. BSI: bloodstream infection; CD: Crohn’s disease; IBD: inflammatory bowel disease; UC: ulcerative colitis.
| Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc |
| Journal website https://www.jocmr.org |
Original Article
Volume 15, Number 5, May 2023, pages 262-267
Characteristics of Patients With Inflammatory Bowel Disease Who Develop Bloodstream Infection
Figures
Tables
| Characteristics | N (%) or median (IQR) | P value | ||
|---|---|---|---|---|
| Total | CD (n = 68) | UC (n = 27) | ||
| aFisher’s exact test. bMann-Whitney U test. BMI: body mass index; BSI: bloodstream infection; CD: Crohn’s disease; IQR: interquartile range; UC: ulcerative colitis. | ||||
| Male | 55 (57.9) | 40 (58.8) | 15 (55.6) | 0.821a |
| Age | 57 (40 - 62) | 50 (39 - 62) | 56 (48 - 67) | 0.194b |
| BMI | 19.6 (17.3 - 21.9) | 19.5 (17.4 - 21.8) | 20.2 (16.9 - 21.9) | 0.662b |
| Diabetes | 7 (7.4) | 5 (7.4) | 2 (7.4) | 1a |
| Length of hospital stay (days) | 11 (1 - 32) | 9 (2 - 24.3) | 15 (6 - 68) | 0.045b |
| Immunosuppressants | 42 (44.2) | 39 (57.4) | 3 (11.1) | 0.00003a |
| Catheter | 28 | 22 | 6 | - |
| Pneumonia | 7 | 6 | 1 | - |
| Pyelonephritis | 20 | 9 | 11 | - |
| Peritonitis | 8 | 5 | 3 | - |
| Bile tube | 4 | 3 | 1 | - |
| Dermatitis | 1 | 1 | 0 | - |
| Enteritis | 2 | 2 | 0 | - |
| Unknown | 25 | 20 | 5 | - |
| Detection bacteriaa | CD (n = 68) (%) | UC (n = 27) (%) | P-valueb |
|---|---|---|---|
| aMulti-fungus detection. bFisher’s exact test. CD: Crohn’s disease; CNS: coagulase-negative staphylococci; MRSA: methicillin-resistant Staphylococcus aureus; UC: ulcerative colitis. | |||
| Gram-positive bacteria | 29 (42.6) | 9 (33.3) | 0.489 |
| Gram-positive streptococcus | 28 (41.2) | 8 (29.6) | 0.353 |
| Enterococcus sp. | 2 (2.9) | 1 (3.7) | 1 |
| Staphylococcus spp. | 23 (33.8) | 7 (10.3) | 0.625 |
| Staphylococcus aureus | 3 (4.4) | 0 | 0.556 |
| MRSA | 1 (1.5) | 2 (7.4) | 0.194 |
| Staphylococcus epidermidis | 16 (23.5) | 5 (18.52) | 0.785 |
| CNS | 3 (4.4) | 0 | 0.556 |
| Streptococcus sp. | 3 (4.4) | 0 | 0.556 |
| Gram-positive bacillus | 1 (1.5) | 1 (3.7) | 0.490 |
| Clostridium subterminale | 1 (1.5) | 0 | 1 |
| Propionibacterium acnes | 0 | 1 (3.7) | 0.284 |
| Gram-negative bacteria | 24 (35.3) | 17 (63.0) | 0.021 |
| Acinetobacter sp. | 3 (4.4) | 0 | 0.556 |
| Corynebacterium sp. | 0 | 1 (3.7) | 0.284 |
| Citrobacter sp. | 2 (2.9) | 1 (3.7) | 1 |
| Cronobacter sakazakii | 0 | 1 (3.7) | 0.284 |
| Enterobacter sp. | 8 (11.8) | 3 (11.1) | 1 |
| Escherichia coli | 7 (10.3) | 2 (7.4) | 1 |
| Fusobacterium nucleatum | 0 | 1 (3.7) | 0.284 |
| Klebsiella pneumoniae | 0 | 3 (11.1) | 0.021 |
| Neisseria sp. | 1 (1.5) | 0 | 1 |
| Pseudomonas aeruginosa | 2 (2.9) | 5 (18.5) | 0.019 |
| Stenotrophomonas maltophilia | 1 (1.5) | 0 | 1 |
| Enterobacteriology bacteria | 26 (38.2) | 10 (37.0) | 1 |
| Anaerritic bacteria | 3 (4.4) | 0 | 0.556 |
| Fungus | 3 (4.4) | 1 (3.7) | 1 |
| The strain is unknown | 9 (13.2) | 0 | |